Immatics Nv Stock Analysis

Immatics Stock Analysis Notes

About 22.0% of the company shares are held by company insiders. The book value of Immatics was currently reported as 2.66. The company recorded a loss per share of 0.63. Immatics NV had not issued any dividends in recent years. Immatics N.V., a clinical-stage biopharmaceutical company, focuses on the discovery and development of T cell receptor based immunotherapies for the treatment of cancer in the United States. The company has a strategic collaboration agreement with GlaxoSmithKline Intellectual Property Development Limited to develop novel adoptive cell therapies targeting multiple cancer indications MD Anderson Cancer Center to develop multiple T cell and TCR-based adoptive cellular therapies Celgene Switzerland LLC to develop novel adoptive cell therapies targeting multiple cancers and Genmab AS to develop T cell engaging bispecific immunotherapies targeting multiple cancer indications. Immatics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 388 people. To learn more about Immatics NV call Harpreet Singh at 49 7071 5397 0 or check out https://www.immatics.com.

Immatics NV Investment Alerts

Immatics NV Upcoming and Recent Events

Immatics Largest EPS Surprises

View All Earnings Estimates

Immatics Environmental, Social, and Governance (ESG) Scores

Immatics Stock Institutional Investors

Note, although Immatics' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Immatics Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 872.73 M.

Immatics Profitablity

The company has Profit Margin (PM) of (1.04) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (1.42) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $1.42.

Management Efficiency

Immatics NV has return on total asset (ROA) of (0.1217) % which means that it has lost $0.1217 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.2432) %, meaning that it created substantial loss on money invested by shareholders. Immatics' management efficiency ratios could be used to measure how well Immatics manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.2 in 2024. Return On Capital Employed is likely to drop to -0.3 in 2024. At this time, Immatics' Net Tangible Assets are fairly stable compared to the past year. Other Assets is likely to rise to about 3.1 M in 2024, whereas Total Assets are likely to drop slightly above 298.3 M in 2024.

Technical Drivers

As of the 17th of December 2024, Immatics retains the Market Risk Adjusted Performance of (1.33), standard deviation of 2.86, and Risk Adjusted Performance of (0.20). Immatics technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Immatics NV Price Movement Analysis

Immatics Outstanding Bonds

Immatics Predictive Daily Indicators

Immatics Corporate Filings

Immatics Forecast Models

Immatics' time-series forecasting models are one of many Immatics' stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Immatics' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Immatics prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Immatics shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Immatics. By using and applying Immatics Stock analysis, traders can create a robust methodology for identifying Immatics entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Immatics analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Immatics analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Immatics NV stock analysis indicators help investors evaluate how Immatics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Immatics shares will generate the highest return on investment. By understating and applying Immatics stock analysis, traders can identify Immatics position entry and exit signals to maximize returns.

When running Immatics' price analysis, check to measure Immatics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immatics is operating at the current time. Most of Immatics' value examination focuses on studying past and present price action to predict the probability of Immatics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immatics' price. Additionally, you may evaluate how the addition of Immatics to your portfolios can decrease your overall portfolio volatility.